DTEA News and Press, DAVIDsTEA Inc. From 05/02/19

DAVIDs TEA (NASDAQ: DTEA ): Q4 Non-GAAP EPS of $0.25; GAAP EPS of -$0.51. More news on: DAVIDsTEA Inc., Earnings news and commentary, Stocks on the move, Consumer stocks news, , Read more ...

Q4 2018 Financial and Operational Highlights: Sales decreased 4.1% to $83.1 million and comparable store sales declined 1.6% 20.2% increase in wholesale and e-commerce sales Operating loss 1 of $1.3 million compared to loss of $8.4 million in Q4-17 Adjusted EBITDA 1 of $10...

MONTREAL, April 25, 2019 (GLOBE NEWSWIRE) -- DAVIDsTEA Inc. (Nasdaq:DTEA) today announced that its financial results for the fourth quarter of fiscal 2018 will be released after market close on Thursday, May 2, 2019. The Company will host a conference call the same day at 4:30 p.m. Easter...

Akari Therapeutics (NASDAQ: AKTX ) +19%  on announcing that it had a successful Type B, pre-IND meeting with the FDA. More news on: Akari Therapeutics, Plc, Pareteum Corporation, PAVmed Inc., Stocks on the move, Read more ...

Gainers:  OncoCyte (NYSEMKT: OCX ) +228% . Voyager Therapeutics (NASDAQ: VYGR ) +36% . Conatus Pharmaceuticals (NASDAQ: CNAT ) +34% . Zynerba Pharmaceuticals (NASDAQ: ZYNE ) +33% . HyreCar (NASDAQ: HYRE ) +21% . Sanmina (NASDAQ: SANM ) +18% . Woodward (NASDAQ: WWD ) +17% . J &a...